A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HCC / Hurthle cell carcinoma

[Related PubMed/MEDLINE]
Total Number of Papers: 55
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HCC  (>> Co-occurring Abbreviation)
Long Form:   Hurthle cell carcinoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Clinicopathological features and outcomes after radioactive iodine treatment of oncocytic well-differentiated thyroid carcinomas. OPTC, RAI
2019 Concurrence of Papillary Thyroid Carcinoma and Hurthle Cell Carcinoma in an Iranian Woman with Hashimoto's Thyroiditis. PTC, TC
2019 Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hurthle Cell Cancer. EGF, EGFR, MAPK, NHG, PI3K, WGS
2018 CHL1 expression differentiates Hurthle cell carcinoma from benign Hurthle cell nodules. CHL1, qRT-PCR
2018 Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hurthle cell carcinoma. CI, FTC, HR
2018 Demographic and histological subtypes of Hurthle cell tumours of the thyroid in a South African setting. HCA, HCNs
2018 Differential expression of serine and glycine metabolism-related proteins between follicular neoplasm and Hurthle cell neoplasm. FA, FC, FN, HCA, HCN
2018 Fluorescence in situ hybridization of thyroid fine-needle aspiration biopsy distinguishes between neoplastic and non-neoplastic Hurthle cell lesions. FISH, FNA, HCA, NH
2018 Hurthle Cell Carcinoma in a Lingual Thyroid. ---
10  2018 Integrated Genomic Analysis of Hurthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes. ---
11  2018 Thyroseq V3 Molecular Profiling for Tailoring the Surgical Management of Hurthle Cell Neoplasms. BC, CNAs, FNAB, PPV
12  2017 Issues in Managing Hurthle Cell Carcinoma of Thyroid: A Case Report. ---
13  2016 Hurthle cell carcinoma: current perspectives. RAI
14  2016 Radioactive Iodine Treatment Is Associated with Improved Survival for Patients with Hurthle Cell Carcinoma. RAI
15  2015 A Rare Silent Killer: Right Atrial Metastasis of Thyroid Hurthle Cell Carcinoma. ---
16  2014 Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data. FTC
17  2014 Mutation profile of differentiated thyroid tumours in an Australian urban population. FC, PCR, RNA
18  2014 Nuclear receptor expression in human differentiated thyroid tumors. FC, IHC, MNG, NRs
19  2013 Does Hurthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma? CSS, OFC
20  2013 Hurthle cell carcinoma: a population-level analysis of 3311 patients. ATA, OR, SEER
21  2013 Hurthle cell carcinoma: an update on survival over the last 35 years. CI, FCC, SEER
22  2012 Histological patterns of locoregional recurrence in Hurthle cell carcinoma of the thyroid gland. ---
23  2012 Mucoepidermoid carcinoma of the thyroid: a report of three cases and postulated histogenesis. FTC, MEC, PTC, WDTCs
24  2011 Localized advanced hurthle cell carcinoma with symptomatic intrathoracic goiter. IG
25  2011 PVALB, a new Hurthle adenoma diagnostic marker identified through gene expression. HCA, ROC
26  2010 Age and tumor size predicts lymph node involvement in Hurthle Cell Carcinoma. LN
27  2010 Cytomorphological features of Hurthle cell carcinoma: A report of two cases with review of literature. ---
28  2010 Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms. FTA, FTC, FVPTC, HCA
29  2009 An unusual case of hurthle cell carcinoma presenting as metastatic pleural disease 16 years after thyroidectomy. ---
30  2009 Hurthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. CSS, DFS, FTC
31  2009 Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors. CN, FA, FC, FVPC, GD, HCA, HT, IMP3, PTC
32  2008 Fine-needle aspiration cytology of Hurthle cell carcinoma of the thyroid. BNHCL, FNA, HCA
33  2008 Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. DSS, FDG, PDTC, PET, RAIR, TC, TCV, WDPTC
34  2008 Older age and larger tumor size predict malignancy in hurthle cell neoplasms of the thyroid. HCA, HCNs
35  2007 Unusual adrenal metastasis and abdominal carcinomatosis secondary to Hurthle cell carcinoma of the thyroid. ---
36  2006 Hurthle cell carcinoma: a clinicopathological study of thirteen cases. ---
37  2006 Surgery for thyroid Hurthle cell tumours--a single institution experience. HCA, HCT
38  2006 Workup of well-differentiated thyroid carcinoma. FTC, PTC, WDTC
39  2005 PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value. FA, FTC
40  2004 A rare case of Hurthle cell carcinoma with endobronchial metastasis. EBM
41  2004 Assessment of proliferative activity of thyroid Hurthle cell tumors using PCNA, Ki-67 and AgNOR methods. HCA, HCM, HCT
42  2004 Does the fine-needle aspiration diagnosis of "Hurthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? FNA, FNOF, HCN
43  2004 Prognostic indications for Hurthle cell cancer. ---
44  2003 Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. HCA
45  2003 The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma. FC, FS, PS, US
46  2002 High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene. FA, FTC, LOH, PTC, TSG
47  2001 Hurthle cell carcinoma. ---
48  2001 Immunohistochemical diagnosis of papillary thyroid carcinoma. AC, CK, FA, FC, FVPC, IC, PC
49  2001 Proliferative activity of the thyroid oxyphilic tumor cells estimated by means of quantitative analysis of silver stained nucleolar organizer regions (AgNORs). AgNORs, AgNORs, HCA, HCM
50  2000 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors. FA, HCA, MTC, PC, SS
51  2000 Huerthle cell neoplasms of the thyroid: predicting malignant potential. FNA, FS, HCN
52  1999 Pitfalls in cytological diagnosis of autoimmune thyroiditis. AT, MNG, PC
53  1999 Proliferative activity of Hurthle cell thyroid tumours. HCA, HCT, PCNA
54  1998 Establishment of a highly differentiated thyroid cancer cell line of Hurthle cell origin. cAMP, hTg
55  1997 Differential diagnosis of Hurthle cell neoplasms on fine needle aspirates. Can we do any better with morphometry? HCA